- £81.29m
- £46.68m
- £35.17m
Transfer of Treasury Shares
Transfer of Treasury Shares
Director/PDMR Shareholding
Brief: Venture Life Says FY Revenue & Adjusted EBITDA In Line With Management Expectations
Full Year Trading Update
Director/PDMR Shareholding
Brief: Venture Life Group Announces Acquisition Of FemiClear And CUROXEN
Acquisition of FemiClear and CUROXEN
Holding(s) in Company
UK's Venture Life FY results lifted by Power Brands, acquisitions; says 2026 rev ahead of 2025
Brief: Venture Life FY Revenue GBP 35.2 Million
Interim Results
Grant of Options and Director Dealing
Holding(s) in Company
PCA Dealing
Exercise of Share Options & Total Voting Rights
Trading Update
Exercise of Share Options & Total Voting Rights
Director/PDMR Shareholding